Physician profile
Michael E Dunham
NPI 1427025675
$1,046.04
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $481 · 2021: $259 · 2022: $156 · 2024: $150.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $150.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $149.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arrinex, INC. | $160.31 | 2019 | |
| Aerin Medical INC. | $135.35 | 2022 | |
| Optinose US, INC. | $122.80 | 2021 | |
| Regeneron Healthcare Solutions, INC. | $121.83 | 2021 | |
| Acclarent, INC | $104.37 | 2019 | |
| Smith+Nephew, INC. | $87.68 | 2019 | |
| Olympus America INC. | $85.00 | 2019 | |
| Spirair, INC. | $59.34 | 2024 | Septalign |
| Medtronic, INC. | $48.75 | 2024 | Straightshot |
| Grace Medical, INC. | $43.98 | 2019 | |
| Integra Lifesciences Corporation | $41.88 | 2024 | Relieva Spinplus Nav, Inspira Air, Acclarent Aera |
| Kerecis Limited | $34.75 | 2021-2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Dunham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.